{"id":138,"date":"2025-10-03T15:19:17","date_gmt":"2025-10-03T15:19:17","guid":{"rendered":"https:\/\/drmariogenero.xyz\/?p=138"},"modified":"2025-10-03T15:31:23","modified_gmt":"2025-10-03T15:31:23","slug":"138","status":"publish","type":"post","link":"https:\/\/drmariogenero.xyz\/?p=138","title":{"rendered":"Geroscience: Transforming Medicine by\u00a0Targeting the\u00a0Biology of Aging"},"content":{"rendered":"\n<p><strong>Overview<\/strong>:  <br>Geroscience is an emerging interdisciplinary field that posits the fundamental mechanisms of biological aging drive most chronic diseases in later life. Instead of targeting individual age-related diseases (like heart disease, diabetes, or cancer) in isolation, geroscience seeks to intervene upstream\u2014at the aging process itself\u2014to delay, attenuate, or prevent the onset of multiple conditions simultaneously.<a href=\"https:\/\/academic.oup.com\/biomedgerontology\/article\/79\/9\/glae179\/7744984\" target=\"_blank\" rel=\"noreferrer noopener\"><\/a><\/p>\n\n\n\n<p>by Dr. Mario Hugo Genero, MD &#8211; Kendall Square &#8211; Cambridge &#8211; MA &#8211; USA (drmariogenero@outlook.com)<\/p>\n\n\n\n<figure class=\"wp-block-image size-full\"><img loading=\"lazy\" decoding=\"async\" width=\"1024\" height=\"1024\" src=\"http:\/\/drmariogenero.xyz\/wp-content\/uploads\/2025\/10\/GEROSCIENCE1.png\" alt=\"\" class=\"wp-image-139\" srcset=\"https:\/\/drmariogenero.xyz\/wp-content\/uploads\/2025\/10\/GEROSCIENCE1.png 1024w, https:\/\/drmariogenero.xyz\/wp-content\/uploads\/2025\/10\/GEROSCIENCE1-300x300.png 300w, https:\/\/drmariogenero.xyz\/wp-content\/uploads\/2025\/10\/GEROSCIENCE1-150x150.png 150w, https:\/\/drmariogenero.xyz\/wp-content\/uploads\/2025\/10\/GEROSCIENCE1-768x768.png 768w\" sizes=\"auto, (max-width: 1024px) 100vw, 1024px\" \/><\/figure>\n\n\n\n<p><strong>Recent Advances<\/strong><br>Recent clinical and translational research has provided increasing support for the \u201cgeroscience hypothesis\u201d\u2014that slowing aging processes will extend healthspan and delay multimorbidity and functional decline. Interventions under current investigation include senolytics, caloric restriction mimetics, and modulators of metabolic and inflammatory pathways. Large-scale collaborative efforts, such as the NIH Geroscience Interest Group (GSIG), are facilitating multisite trials and bringing together diverse expertise to accelerate discovery and translation.<a href=\"https:\/\/www.nia.nih.gov\/gsig\" target=\"_blank\" rel=\"noreferrer noopener\"><\/a><\/p>\n\n\n\n<p>Innovative clinical trials are being designed to test anti-aging therapeutics in humans, though these present unique methodological challenges. Unlike traditional disease-specific trials, endpoints for geroscience interventions must capture improvements in function, quality of life, and resilience, sometimes over long follow-up periods. Experts emphasize the priority of patient-reported outcomes and validated measures of frailty and physical function when evaluating impact.<a rel=\"noreferrer noopener\" target=\"_blank\" href=\"https:\/\/www.nature.com\/articles\/s41467-023-39786-7\"><\/a><\/p>\n\n\n\n<p><strong>Opportunities and Challenges<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>There is growing recognition that interventions targeting aging biology hold the potential for greater impact on population health than any single-disease cure.<a href=\"https:\/\/www.news-medical.net\/news\/20250818\/Scientists-urge-shift-in-medicine-to-target-the-biology-of-aging.aspx\" target=\"_blank\" rel=\"noreferrer noopener\"><\/a><\/li>\n\n\n\n<li>Major challenges include establishing endpoints, ensuring diversity and inclusivity in research cohorts, and standardizing biomarkers and outcome measures.<a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC12323501\/\" target=\"_blank\" rel=\"noreferrer noopener\"><\/a><\/li>\n\n\n\n<li>The Fourth Geroscience Summit (2024) highlighted the need for collaborative, interdisciplinary, and global approaches, including training a diverse workforce and focusing research on both biological and social determinants of healthy aging.<a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC12084117\/\" target=\"_blank\" rel=\"noreferrer noopener\"><\/a><\/li>\n<\/ul>\n\n\n\n<p><strong>Key References (2023\u20132025)<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Kritchevsky SB. &#8220;Geroscience: A Translational Review.&#8221; 2025.<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/40773213\/\" target=\"_blank\" rel=\"noreferrer noopener\"><\/a><\/li>\n\n\n\n<li>Addie S et al. &#8220;Considering the Future of Geroscience: Goals and Opportunities Stemming From the Fourth Geroscience Summit.&#8221; J Gerontol A Biol Sci Med Sci. 2024;79(9):glae179.<a href=\"https:\/\/academic.oup.com\/biomedgerontology\/article\/79\/9\/glae179\/7744984\" target=\"_blank\" rel=\"noreferrer noopener\"><\/a><\/li>\n\n\n\n<li>Rolland Y et al. &#8220;Challenges in developing Geroscience trials.&#8221; Nat Commun. 2023;14:4896.<a href=\"https:\/\/www.nature.com\/articles\/s41467-023-39786-7\" target=\"_blank\" rel=\"noreferrer noopener\"><\/a><\/li>\n\n\n\n<li>Cummings SR, Kritchevsky SB. &#8220;Scientists urge shift in medicine to target the biology of aging.&#8221; JAMA. 2025.<a href=\"https:\/\/www.news-medical.net\/news\/20250818\/Scientists-urge-shift-in-medicine-to-target-the-biology-of-aging.aspx\" target=\"_blank\" rel=\"noreferrer noopener\"><\/a><\/li>\n\n\n\n<li>Muscedere J et al. &#8220;Advancing Geroscience Research \u2013 A Scoping Review.&#8221; 2025.<a href=\"https:\/\/www.sciencedirect.com\/science\/article\/pii\/S1279770725001629\" target=\"_blank\" rel=\"noreferrer noopener\"><\/a><\/li>\n\n\n\n<li>National Institute on Aging, Geroscience Interest Group (GSIG).<a href=\"https:\/\/www.nia.nih.gov\/gsig\" target=\"_blank\" rel=\"noreferrer noopener\"><\/a><\/li>\n\n\n\n<li>Nielsen L et al. &#8220;Integrating Social and Behavioral Drivers of Biological Aging.&#8221; 2024.<a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC12084117\/\" target=\"_blank\" rel=\"noreferrer noopener\"><\/a><\/li>\n\n\n\n<li>Harinath G et al. &#8220;The role of quality of life data as an endpoint for collecting in geroscience clinical trials.&#8221; 2024.<a href=\"https:\/\/www.sciencedirect.com\/science\/article\/pii\/S1568163724001119\" target=\"_blank\" rel=\"noreferrer noopener\"><\/a><\/li>\n<\/ul>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<p>Geroscience is rapidly reshaping our understanding and management of aging and age-related diseases, offering a paradigm shift for preventive medicine and therapeutic innovation.Here is a newsletter draft on Geroscience for physicians and researchers, with up-to-date references:<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h2 class=\"wp-block-heading\">Geroscience: A New Paradigm in Healthcare and Aging<\/h2>\n\n\n\n<p><strong>What is Geroscience?<\/strong><br>Geroscience is an interdisciplinary field at the intersection of aging biology and medicine, proposing that addressing the fundamental mechanisms of aging can delay, prevent, or attenuate multiple chronic diseases simultaneously, rather than treating them one by one. The goal is to extend \u201chealthspan\u201d\u2014years of life spent in good health\u2014by targeting molecular drivers of aging.<a rel=\"noreferrer noopener\" target=\"_blank\" href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/40773213\/\"><\/a><\/p>\n\n\n\n<p><strong>Recent Developments &amp; Opportunities<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Major research consortia, like the NIH Geroscience Interest Group (GSIG), are catalyzing collaborative basic and translational science, while also focusing on training a diverse research workforce and including underrepresented populations.<a href=\"https:\/\/academic.oup.com\/biomedgerontology\/article\/79\/9\/glae179\/7744984\" target=\"_blank\" rel=\"noreferrer noopener\"><\/a><\/li>\n\n\n\n<li>Innovative clinical trials are underway, investigating interventions such as senolytics, caloric restriction mimetics, and metabolic modulators. Unlike disease-specific trials, geroscience research prioritizes quality of life, function, and resilience as primary endpoints.<a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC11844647\/\" target=\"_blank\" rel=\"noreferrer noopener\"><\/a><\/li>\n\n\n\n<li>New evidence highlights the value of measuring biological age via molecular and functional biomarkers, as well as considering behavioral and social influences on aging trajectories.<a href=\"https:\/\/www.frontiersin.org\/journals\/aging\/articles\/10.3389\/fragi.2025.1658952\/full\" target=\"_blank\" rel=\"noreferrer noopener\"><\/a><\/li>\n<\/ul>\n\n\n\n<p><strong>Challenges<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Designing appropriate trial endpoints and ensuring long-term follow-up remain key obstacles.<a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC11844647\/\" target=\"_blank\" rel=\"noreferrer noopener\"><\/a><\/li>\n\n\n\n<li>Inclusion, diversity, and equity in research populations are essential for robust, generalizable results and were prominently discussed at recent field-wide summits.<a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC12084117\/\" target=\"_blank\" rel=\"noreferrer noopener\"><\/a><\/li>\n<\/ul>\n\n\n\n<p><strong>Key Recent References (2023\u20132025):<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Kritchevsky SB. &#8220;Geroscience: A Translational Review.&#8221; 2025.<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/40773213\/\" target=\"_blank\" rel=\"noreferrer noopener\"><\/a><\/li>\n\n\n\n<li>Addie S et al. &#8220;Considering the Future of Geroscience: Goals and Opportunities Stemming From the Fourth Geroscience Summit.&#8221; J Gerontol A Biol Sci Med Sci. 2024;79(9):glae179.<a href=\"https:\/\/academic.oup.com\/biomedgerontology\/article\/79\/9\/glae179\/7744984\" target=\"_blank\" rel=\"noreferrer noopener\"><\/a><\/li>\n\n\n\n<li>Rolland Y et al. &#8220;Challenges in developing Geroscience trials.&#8221; Nat Commun. 2023;14:39786.<a href=\"https:\/\/www.nature.com\/articles\/s41467-023-39786-7\" target=\"_blank\" rel=\"noreferrer noopener\"><\/a><\/li>\n\n\n\n<li>Harinath G et al. &#8220;The role of quality of life data as an endpoint for collecting in geroscience clinical trials.&#8221; 2024.<a href=\"https:\/\/www.sciencedirect.com\/science\/article\/pii\/S1568163724001119\" target=\"_blank\" rel=\"noreferrer noopener\"><\/a><\/li>\n\n\n\n<li>National Institute on Aging, Geroscience Interest Group (GSIG), 2024.<a href=\"https:\/\/www.nia.nih.gov\/gsig\" target=\"_blank\" rel=\"noreferrer noopener\"><\/a><\/li>\n\n\n\n<li>Nielsen L et al. &#8220;Integrating Social and Behavioral Drivers of Biological Aging.&#8221; 2024.<a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC12084117\/\" target=\"_blank\" rel=\"noreferrer noopener\"><\/a><\/li>\n<\/ul>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<p>Geroscience heralds a transformative era for medicine by focusing on the biology of aging itself, creating<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Overview: Geroscience is an emerging interdisciplinary field that posits the fundamental mechanisms of biological aging drive most chronic diseases in later life. Instead of targeting individual age-related diseases&#8230; <\/p>\n","protected":false},"author":1,"featured_media":139,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[15,6,7,3],"tags":[],"class_list":["post-138","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-geroscience","category-homo-sapiens","category-omics","category-precision-medicine"],"_links":{"self":[{"href":"https:\/\/drmariogenero.xyz\/index.php?rest_route=\/wp\/v2\/posts\/138","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/drmariogenero.xyz\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/drmariogenero.xyz\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/drmariogenero.xyz\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/drmariogenero.xyz\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=138"}],"version-history":[{"count":6,"href":"https:\/\/drmariogenero.xyz\/index.php?rest_route=\/wp\/v2\/posts\/138\/revisions"}],"predecessor-version":[{"id":147,"href":"https:\/\/drmariogenero.xyz\/index.php?rest_route=\/wp\/v2\/posts\/138\/revisions\/147"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/drmariogenero.xyz\/index.php?rest_route=\/wp\/v2\/media\/139"}],"wp:attachment":[{"href":"https:\/\/drmariogenero.xyz\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=138"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/drmariogenero.xyz\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=138"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/drmariogenero.xyz\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=138"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}